Neurofascin as a target for autoantibodies in peripheral neuropathies
Judy King Man Ng(Frauenklinik der Technischen Universität München), Edgar Meinl(Ludwig-Maximilians-Universität München), Claudia Sommer(Universitätsklinikum Würzburg), Tomas Olsson(Karolinska University Hospital), Nobuhiro Yuki(Dokkyo University), Christopher Linington(Centre for Immunity, Infection and Evolution), Björn Tackenberg(Universitätsklinikum Gießen und Marburg), Naoto Kawakami(Ludwig-Maximilians-Universität München), Reinhard Hohlfeld(Munich Cluster for Systems Neurology), Harald Prüß(German Center for Neurodegenerative Diseases), Joachim Malotka(Institute of Neuroimmunology of the Slovak Academy of Sciences), Mohsen Khademi(Karolinska University Hospital), Hendrik Harms(Institute of Neuroimmunology of the Slovak Academy of Sciences), Klaus Dornmair(Institute of Neuroimmunology of the Slovak Academy of Sciences), Lutz Harms(Universität Hamburg), Jan M. Schwab(The Ohio State University Wexner Medical Center), Tobias Derfuß(University of Basel), Matthew N. Rasband(Baylor College of Medicine), Yael Eshed‐Eisenbach(Institute of Neuroimmunology of the Slovak Academy of Sciences), Masaaki Odaka(Dokkyo University), Elior Peles(Weizmann Institute of Science)
Cited by 246
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
|Annals of Neurology|2010|728